205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-43.99%
Both yoy net incomes decline, with AVGO at -9.78%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-197.51%
Both negative yoy, with AVGO at -33.99%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
-113.53%
Negative yoy CFO while AVGO is 7.23%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
-3.24%
Both yoy lines negative, with AVGO at -44.00%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
No Data
No Data available this quarter, please select a different quarter.
94.49%
Purchases well above AVGO's 45.71%. Michael Burry would see major cash outflow into securities vs. competitor’s approach, risking near-term FCF.
-47.64%
We reduce yoy sales while AVGO is 333.33%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
No Data
No Data available this quarter, please select a different quarter.
24.40%
Investing outflow well above AVGO's 23.56%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
No Data
No Data available this quarter, please select a different quarter.
-75.00%
Negative yoy issuance while AVGO is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
No Data
No Data available this quarter, please select a different quarter.